Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

2.

Antioxidant vitamin supplementation reduces benzo(a)pyrene-DNA adducts and potential cancer risk in female smokers.

Mooney LA, Madsen AM, Tang D, Orjuela MA, Tsai WY, Garduno ER, Perera FP.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):237-42.

3.

Effect of a 4-month tea intervention on oxidative DNA damage among heavy smokers: role of glutathione S-transferase genotypes.

Hakim IA, Harris RB, Chow HH, Dean M, Brown S, Ali IU.

Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):242-9.

4.

Oxidative-inflammatory damage in cirrhosis: effect of vitamin E and a fermented papaya preparation.

Marotta F, Yoshida C, Barreto R, Naito Y, Packer L.

J Gastroenterol Hepatol. 2007 May;22(5):697-703.

PMID:
17444858
5.

Is there a potential application of a fermented nutraceutical in acute respiratory illnesses? An in-vivo placebo-controlled, cross-over clinical study in different age groups of healthy subjects.

Marotta F, Naito Y, Jain S, Lorenzetti A, Soresi V, Kumari A, Carrera Bastos P, Tomella C, Yadav H.

J Biol Regul Homeost Agents. 2012 Apr-Jun;26(2):285-94.

PMID:
22824755
6.

Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and the glutathione-S-transferase M1 genotype.

Grinberg-Funes RA, Singh VN, Perera FP, Bell DA, Young TL, Dickey C, Wang LW, Santella RM.

Carcinogenesis. 1994 Nov;15(11):2449-54.

PMID:
7955090
7.

Benzo(a)pyrene diolepoxide (BPDE)-DNA adduct levels in leukocytes of smokers in relation to polymorphism of CYP1A1, GSTM1, GSTP1, GSTT1, and mEH.

Lodovici M, Luceri C, Guglielmi F, Bacci C, Akpan V, Fonnesu ML, Boddi V, Dolara P.

Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1342-8.

8.
9.

Nutraceutical strategy in aging: targeting heat shock protein and inflammatory profile through understanding interleukin-6 polymorphism.

Marotta F, Koike K, Lorenzetti A, Naito Y, Fayet F, Shimizu H, Marandola P.

Ann N Y Acad Sci. 2007 Nov;1119:196-202.

PMID:
18056967
10.

The effects of diet on DNA bulky adduct levels are strongly modified by GSTM1 genotype: a study on 634 subjects.

Palli D, Masala G, Peluso M, Gaspari L, Krogh V, Munnia A, Panico S, Saieva C, Tumino R, Vineis P, Garte S.

Carcinogenesis. 2004 Apr;25(4):577-84. Epub 2003 Dec 4.

PMID:
14656945
11.

Glutathione S-transferase polymorphisms influence the level of oxidative DNA damage and antioxidant protection in humans.

Dusinská M, Ficek A, Horská A, Raslová K, Petrovská H, Vallová B, Drlicková M, Wood SG, Stupáková A, Gasparovic J, Bobek P, Nagyová A, Kováciková Z, Blazícek P, Liegebel U, Collins AR.

Mutat Res. 2001 Oct 1;482(1-2):47-55.

PMID:
11535248
12.

Effect of a fermented nutraceutical on thioredoxin level and TNF-alpha signalling in cirrhotic patients.

Marotta F, Chui DH, Jain S, Polimeni A, Koike K, Zhou L, Lorenzetti A, Shimizu H, Yang H.

J Biol Regul Homeost Agents. 2011 Jan-Mar;25(1):37-45.

PMID:
21382272
13.

Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City.

Romieu I, Sienra-Monge JJ, Ramírez-Aguilar M, Moreno-Macías H, Reyes-Ruiz NI, Estela del Río-Navarro B, Hernández-Avila M, London SJ.

Thorax. 2004 Jan;59(1):8-10.

14.

Biomarkers of dietary intake of micronutrients modulate DNA adduct levels in healthy adults.

Palli D, Masala G, Vineis P, Garte S, Saieva C, Krogh V, Panico S, Tumino R, Munnia A, Riboli E, Peluso M.

Carcinogenesis. 2003 Apr;24(4):739-46.

PMID:
12727803
15.

The role of GSTM1 and GSTT1 polymorphisms in head and neck cancer risk.

Suzen HS, Guvenc G, Turanli M, Comert E, Duydu Y, Elhan A.

Oncol Res. 2007;16(9):423-9.

PMID:
18074677
16.

[Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].

Gu YF, Zhang ZD, Zhang SC, Zheng SH, Jia HY, Gu SX.

Zhonghua Yi Xue Za Zhi. 2007 Nov 20;87(43):3064-8. Chinese.

PMID:
18261353
17.

Genetic polymorphism of GSTT1 and GSTM1 and susceptibility to chronic obstructive pulmonary disease (COPD).

Faramawy MM, Mohammed TO, Hossaini AM, Kashem RA, Abu Rahma RM.

J Crit Care. 2009 Sep;24(3):e7-10. doi: 10.1016/j.jcrc.2009.06.004.

PMID:
19664521
18.

Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.

Singh M, Shah PP, Singh AP, Ruwali M, Mathur N, Pant MC, Parmar D.

Mutat Res. 2008 Feb 1;638(1-2):184-94. Epub 2007 Oct 16.

PMID:
18035380
19.

Influence of p53 codon 72 exon 4, GSTM1, GSTT1 and GSTP1*B polymorphisms in lung cancer risk in a Brazilian population.

Honma HN, De Capitani EM, Perroud MW Jr, Barbeiro AS, Toro IF, Costa DB, Lima CS, Zambon L.

Lung Cancer. 2008 Aug;61(2):152-62. doi: 10.1016/j.lungcan.2007.12.014. Epub 2008 Feb 14.

PMID:
18280004
20.

Smoking and disease severity in rheumatoid arthritis: association with polymorphism at the glutathione S-transferase M1 locus.

Mattey DL, Hutchinson D, Dawes PT, Nixon NB, Clarke S, Fisher J, Brownfield A, Alldersea J, Fryer AA, Strange RC.

Arthritis Rheum. 2002 Mar;46(3):640-6.

Supplemental Content

Support Center